Home Trending Stocks Tyme Technologies, Inc. (TYME) stock surged in the after-market trading session

Tyme Technologies, Inc. (TYME) stock surged in the after-market trading session

In the after-hours trading session, at the last check, TYME stock had surged by 6.98% to $1.38. TYME stock closed the previous session at $1.29. The TYME stock volume traded 2.44 million shares. In the past year up to date, TYME shares have plunged by -24.12% however in the past week they moved by 10.26%. In the past three and six months, the stock has shed -46.03% and added 36.23%. Furthermore, Tyme Technologies is currently valued in the market at $203.78 million and has 130.17 million outstanding shares.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

What you need to know about Tyme Technologies Inc

Tyme Technologies, Inc. is a clinical-stage biotechnology company that centers on the creation on innovative therapeutics and treatments that are there to fulfill the unmet needs of patients. The organization was initially known as Global Group Enterprises Corp. Tyme Technologies, Inc. was established in 2011 and is settled in New York.

5 Stocks Under $10 That Are Poised to Take Off

Investing in stocks under $10 could significantly increase the returns on your portfolio, especially if you pick the right stocks! Within this report you will find 5 top stocks that offer investors huge upside potential and the best bang for their buck.

Add them to your watchlist before they take off!

Get the Top 5 Stocks Now!

Sponsored

Read More

The company specifically focuses on cancer metabolism-based therapies (CMBTs). TYME has set up its operations in the United States. Its lead investigative up-and-comer is the SM-88 is a cancer metabolism-based therapy that is in Phase II/III clinical preliminary trial to treat a broad range of diseases which total at 15, including, sarcoma lymphoma, pancreatic, lung, prostate, and bosom; that are planned to be extensively viable across tumor types and have low harmfulness profiles. The Company’s remedial methodology is uniquely intended to exploit a malignant growth cell’s inborn metabolic shortcomings to bargain its protections, prompting cell passing through oxidative pressure and openness to the body’s normal insusceptible framework. With the improvement of TYME-18 and TYME-19, the Company accepts that it is likewise arising as an innovator in the advancement of bile acids as possible treatments for disease and infections, for example, COVID-19.

The organization likewise offers TYME-18, which is also a cancer metabolism-based therapy compound that is in the preclinical stage for the treatment of strong tumors. Tyme Technologies, Inc. has an investigation collaborated effort with NYU Langone Health to propel the improvement of therapies for patients with metastatic malignancies, including pancreatic disease, just as with Mayo Clinic; and essential cooperation with Eagle Pharmaceuticals, Inc. to propel oral SM-88 for the therapy of patients with the disease.

What is the recent update in the company?

On 13th May 2021, TYME stock declared that it has named Frank L. Porfido as its Chief Financial Officer, compelling not long after the Company records its yearly report on Form 10-K. Forthcoming has set up a chief with more than 25 years of vital monetary authority experience across little to huge size clinical and business stage Pharma organizations. Mr. Porfido is a Certified Public Accountant and did his BBA while specializing in Accounting-CPA Prep from Pace University, with his MBA done from Farleigh Dickinson University in Finance.

What does the company aim to do after hiring Frank as CFO?

CFO is a significant achievement for the Company as it is tirelessly attempting to finish the essential survey of the pipeline advancement programs. Up-and-comers like straightforward have administration and mastery that will be a priceless segment as the Company positions itself to push ahead and execute on the methodologies ahead. The organization hopes to be to giving more updates as it rollouts the outcomes from its essential audit in June.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

TYME is ready for a groundbreaking year. The Company accepts there is enormous potential for the Company ahead and will require the aptitude of Frank for creating and carrying out essential field-tested strategies that he has accumulated throughout the span of his vocation will advantageously give the fundamental understanding as TYME progresses its endeavors.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

Tyme Technologies, Inc. (TYME) Stock Trends downwards Following Strong Q4 2021 Financials and Progress in OASIS Trial

Tyme Technologies, Inc. (TYME) stock prices was down by -6.92% shortly after market trading commenced on June 11th, 2021, bringing the price per share...

Prophase Labs Inc. (PRPH) stock surged during pre-market trading session. Let’s figure out why?

Prophase Labs Inc. (NASDAQ: PRPH) stock soared by 5.87% at last close as well as the PRPH stock price has been observed rising by...

Why Surgalign Holdings, Inc. (SRGA) stock is gloomy today?

Surgalign Holdings, Inc. (SRGA) stock announced the $50 million registered direct offering priced at the market under Nasdaq rules today on June 10, 2021,...

Exela Technologies Inc. (XELA) stock soars during pre-market. Here’s what you should know?

Exela Technologies Inc. (NASDAQ: XELA) stock gained by 8.28% at last close while the XELA stock price rises in the pre-market as well, by...

Atossa Therapeutics, Inc. (ATOS) stock gains during pre-market trading. Here’s to know why?

Atossa Therapeutics, Inc. (NASDAQ: ATOS) stock declined by 27.51% at the last close while the ATOS stock price rises further by 9.09% in the...

Magnachip Semiconductor Corporation (MX) stock is Popping High today: Why is it so?

Shares of the Magnachip Semiconductor Corporation (MX) stock were popping high after the announcement of its receival of unsolicited buyout bid from Cornucopia Investment...

Why is Autolus Therapeutics plc (AUTL) stock rising today?

Shares of  Autolus Therapeutics plc (AUTL) stock were rising today on June 11, 2021, following the release of the presentation data related to obe-cel...

Mustang Bio, Inc. (MBIO) stock is climbing today: Here is to know why.

Mustang Bio, Inc. (MBIO) stock announced the updated interim data from Phase 1/2 clinical trial of its MB-106 CD20-targeted, autologous CAR T today on...

Related News

Tyme Technologies, Inc. (TYME) Stock Trends downwards Following Strong Q4 2021 Financials and Progress in OASIS Trial

Tyme Technologies, Inc. (TYME) stock prices was down by -6.92% shortly after market trading commenced on June 11th, 2021, bringing the price per share...

Prophase Labs Inc. (PRPH) stock surged during pre-market trading session. Let’s figure out why?

Prophase Labs Inc. (NASDAQ: PRPH) stock soared by 5.87% at last close as well as the PRPH stock price has been observed rising by...

Why Surgalign Holdings, Inc. (SRGA) stock is gloomy today?

Surgalign Holdings, Inc. (SRGA) stock announced the $50 million registered direct offering priced at the market under Nasdaq rules today on June 10, 2021,...

Exela Technologies Inc. (XELA) stock soars during pre-market. Here’s what you should know?

Exela Technologies Inc. (NASDAQ: XELA) stock gained by 8.28% at last close while the XELA stock price rises in the pre-market as well, by...

Atossa Therapeutics, Inc. (ATOS) stock gains during pre-market trading. Here’s to know why?

Atossa Therapeutics, Inc. (NASDAQ: ATOS) stock declined by 27.51% at the last close while the ATOS stock price rises further by 9.09% in the...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.

Get Notified Of Insider Trades, Analyst Upgrades & Downgrades, Earnings Updates & Best Stocks To Trade Every Single Morning

100% free. stop anytime no spam